Shares of Replimune Group, Inc. (REPL) have gained 2.7% over the past four weeks to close the last trading session at $7.16, but there could still be a solid upside left in the stock if short-term ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

Some call it magic -- the ability to make objects appear suddenly out of nowhere. You can create this kind of magic on your website using a few lines of JavaScript ...

March 31, 2026 • An end to birthright citizenship would mean a new layer of bureaucracy for all babies born in the U.S. and could cause delays for health insurance and other benefits. March 31, 2026 • ...

Java has endured radical transformations in the technology landscape and many threats to its prominence. What makes this technology so great, and what does the future hold for Java? In a world ...

TIOBE Index for March 2026: Top 10 Most Popular Programming Languages Your email has been sent Python keeps the top spot as its rating dips again, C climbs further in second, and the bottom stays ...

Replimune Group, Inc. is a clinical-stage biotechnology company. It engages in the business of developing oncolytic immunotherapies for the treatment of cancer. The company was founded by Philip ...